Specialty Pharmaceutical Distributor BDI Pharma Ramps Up Growth Initiative With Recent Expansion in Both Current and New Facilities

COLUMBIA, S.C., March 24, 2014 /PRNewswire/ -- BDI Pharma, Inc. recently completed construction of a new, state-of-the-art refrigeration unit, tripling the company's cold storage capacity along with new frozen storage capabilities.  Additionally, BDI closed on a neighboring, 13,000 square foot building providing for the expansion necessary to accomplish many of the company's key strategic initiatives.  The new facility is located in the same business park as BDI Pharma's headquarters.

Photo - http://photos.prnewswire.com/prnh/20140324/PH88507-a
Photo - http://photos.prnewswire.com/prnh/20140324/PH88507LOGO-b

"The addition of new cold space was vital for the continued growth of the company and further indicates a strong commitment from ownership to continue investing in the rapid growth of BDI Pharma for the coming years," stated Manuel Martinez, Vice President of Operations for BDI Pharma.  "Along with BDI's sustained growth, recent contract wins utilizing our alternative distribution program, Linear B Exchange, have dictated the further expansion of our frozen storage capabilities."

The newly purchased facility will house current and future employees assisting with the company's growth in service capabilities.  "We were fortunate to be able to acquire a second building within walking distance of our headquarters allowing us to grow our business and expand our corporate campus without any interruption in service," stated Richard Gaton, Co-President of BDI Pharma.  "We had a banner year in 2013 with revenue growth of nearly 40% compared to fiscal year 2012.  The additional office space will enable BDI to sustain the continued growth trend as we approach our twentieth anniversary."

About BDI Pharma, Inc.

BDI Pharma has continuously refined the concept of niche distribution, providing solutions beyond the traditional wholesaler model since 1995.  We operate as an extension of our partners' sales force, create demand, and move market share with each transaction.  In this regard, we maintain a highly selective process when entering into a strategic partnership.  Our approach of serving the manufactures as well as the customers over nearly two decades has proven successful in varied market conditions.  This is further supplemented through innovative supply solutions, extensive product knowledge, 24/7 emergency availability and urgent need delivery.  An open-access resource for reference material, educational literature, market data and online ordering, BDI Pharma's home web page www.bdipharma.com  (also www.ivig.com) has become an industry-renowned point of reference.  Proprietary programs covering comprehensive reimbursement services - www.bdiaccess.com and 855-BDI-CARE; and product consignment - www.bdivantageplus.com; are just a few of the solutions tailored to the needs of the healthcare community.

BDI Pharma's product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, coagulation factors, high-titer or "hyper" immune globulins, and other specialty injectables.  BDI Pharma is recognized as an "ADR," or Authorized Distributor of Record, for all of the manufacturers it represents.

Read more news from BDI Pharma, Inc.

Contact: Brad Davis
800-948-9834
Email 

SOURCE BDI Pharma, Inc.